Skip to main Content

About Us

Lab

Applied DNA Sciences is a biotechnology company with over 20 years of experience in developing and commercializing polymerase chain reaction (PCR)-based applications for DNA production. Through our majority-owned subsidiary, LineaRx Inc., we are commercializing the LineaDNA and LineaIVT platforms to enable the manufacture of the next generation of nucleic acid-based therapies.

 


 

Management Team

Judith Murrah

Judy Murrah

Chairperson of the Board, President and Chief Executive Officer

Beth Jantzen

Beth Jantzen

Chief Financial Officer

Clay Shorrock, Esq.

Clay Shorrock

Chief Legal Officer and Executive Director, Business Development, Applied DNA Sciences, and President, LineaRx, Inc.

Stock Information

 

Shareholder Info – Investor Relations

Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, NY 11790
investor@adnas.com | 631.240.8800

Sanjay M. Hurry
Executive Director, Investor Relations and Corporate Communications
sanjay.hurry@adnas.com | M: 917-733-5573

Transfer Agent

American Stock Transfer and Trust Company
6201 15th Ave.
Brooklyn, New York 11219
Tel: 718.921.8210
Fax: 718.921.8355
http://www.amstock.com/main/

For additional information, please click here.

SEC Counsel

McDermott Will & Emery LLP
One Vanderbilt Avenue
New York, NY 10017-3852
T: 212-547-5400

.
Applied DNA Sciences is not able to purchase shares on your behalf, and it is not possible for you to purchase shares directly from us. Please contact a stockbroker, bank, or independent financial advisor, who should be able to act on your behalf.

Auditor

Marcum LLP
10 Melville Park Road
Melville, NY 11790
tel: 631 414 4000
fax: 631 414 4001
http://www.marcumllp.com

APDN Share Price

Board of Directors

Applied DNA’s Board of Directors consists of individuals with proven leadership skills, broad management experience
in
established companies, and their reputation as independent thinkers.

With experience in fields ranging from Bioagriculture to Zoology, the company will continue to benefit from the
Board’s diversity of experience and opinions.

James Hayward BOD

Judith Murrah

Chairperson of the Board, President and Chief Executive Officer

Jospeh Ceccoli

Joseph Ceccoli

Compensation Committee Member
Audit Committee Member

Yacov Shamash

Dr. Yacov Shamash

Chair of Compensation and Nominating Committees; Audit Committee Member

Sanford Simon

Dr. Sanford R. Simon

Nominating Committee Member